VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that its wholly-owned subsidiaries ...
VANCOUVER, BC / ACCESSWIRE / August 18, 2022 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the "Company" or "Core One"), further to its press release dated March 4, 2022, ...
VANCOUVER, British Columbia, Nov. 5, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") is issuing this news release to ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN: A3CSSU) (the "Company" or "Core One") is pleased to announce that its wholly-owned ...
VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce it has ...
GMP Drug Inc., a wholly-owned subsidiary of Core One Labs Inc. CLABF COOLLD (WKN: A3CSSU) has entered into a non-binding letter of intent with Zollaris Laboratories Corporation, an arms-length party, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback